Home » Blog » Grant to Support Drug for Hearing Loss Treatment- April 2016- The ASHA Leader

Grant to Support Drug for Hearing Loss Treatment- April 2016- The ASHA Leader

A $2.06 million NIH Phase 2 grant was given to Oricula Therapeutics, LLC to help support the development of a drug that can prevent hearing loss caused by aminoglycoside antibiotics. These anti-biotics are given to individuals who have serious infectious diseases, such as septicemia and tuberculosis and have been known to cause irreversible hearing loss or even deafness in 20% of this population.

Share


Leave a Reply

Your email address will not be published.

Meet The Team

ENT Surgery in Plainsboro, NJ
Masks are required in our office. We follow CDC guidelines for medical offices. Please call our telephone number before entering the office.
+